Archie C. Reyes

Enzymologist | Biochemist | Scientist at Enanta Pharmaceuticals

[Enanta Pharmaceuticals @EnantaPharma]

Congratulations to members of Team Enanta for their publication in @NatureComms highlighting the preclinical data of EDP-235, Enanta’s 3CL protease inhibitor, in development for the treatment of #COVID-19. Thanks to everyone who made this publication possible and to first author Michael Rhodin who gives us permission to share this link.
https://t.co/VMWPwFcnXO

[Archie C. Reyes @zymotweets]

Our work on the efficacy of EDP-235, a small molecule inhibitor of SARS-CoV2 3CLpro is now published!

https://t.co/wbu8rbf5OV

[Enanta Pharmaceuticals @EnantaPharma]

It was a beautiful spring day for a 5K! Congrats to our Enanta colleagues who ran the Boston Athletic Association 5K this past weekend. #BAA5K

[Enanta Pharmaceuticals @EnantaPharma]

We had another successful Lunch & Learn with #WatertownSchool students. Twenty-three future scientists, 2 teachers, and the Assistant Superintendent of Watertown schools came for the program. Thanks to Harry Trout III for making it possible. #WatertownHighSchool #LunchandLearn

[Paul Thompson @Pthompsn1018]

Latest from the lab: Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2 https://t.co/SS90DkCrVz

[Enanta Pharmaceuticals @EnantaPharma]

This morning we announced the initiation of SPRINT, our Phase 2 clinical study of EDP-235, our lead oral 3CL protease inhibitor, in development for the treatment of COVID-19. For more details, read here: https://t.co/HUcMJNMhJt

[Archie C. Reyes @zymotweets]

@elgin_chem OMG!! hahaha

[Enanta Pharmaceuticals @EnantaPharma]

Congratulations to members of Team Enanta for giving multiple presentations at the 12th International RSV Symposium, which was recently held at ICC Belfast in Northern Ireland, United Kingdom. We couldn’t be prouder. To view the presentations, visit here: https://t.co/QGpecxqrP1

[Enanta Pharmaceuticals @EnantaPharma]

It's National Chemistry Week and we couldn't let it end without giving a shout out to all the amazing chemists at Enanta. We are thankful for your hard work and so proud of all you have accomplished for the company. #chemistry #RSV #COVID #hMPV #HBV

[Enanta Pharmaceuticals @EnantaPharma]

Today we announced that new preclinical data for EDP-235, our oral, direct-acting antiviral protease inhibitor specifically designed for the treatment of COVID-19 will be presented at IDWeek 2022 on Friday. To read the press release, visit here: https://t.co/R5LSJDNz9W

[Enanta Pharmaceuticals @EnantaPharma]

Congrats to Team Enanta for presenting data on EDP-235, our oral 3CL protease inhibitor designed for the treatment COVID-19, at the 2022 ASBMB Annual Meeting held in conjunction w/ Experimental Biology 2022. To see the poster and presentation, visit here: https://t.co/QGpecx9oN1

[Enanta Pharmaceuticals @EnantaPharma]

Great to be recognized for EDP-235, our COVID-19 antiviral candidate, which is in the clinic. As we like to say, #GreatChemistryCures. #covid19news
https://t.co/67mYQg4oZH

[Enanta Pharmaceuticals @EnantaPharma]

As our pipeline continues to grow, it was time for a fresh new look, with a clearly defined mission, vision and values. Come see our new look at https://t.co/VWEtGcXD0y and hear from our employees.
#GreatChemistryCures

[Archie C. Reyes @zymotweets]

@elgin_chem MacBook na Kuya!

[Archie C. Reyes @zymotweets]

@janica_magat @fhollenbach Congratulations Dra Mumsh! @janica_magat

[Archie C. Reyes @zymotweets]

@elgin_chem Pauso yan ng mga kano. Puro ganyan sila dito. Akala pati nila entitled na sila sa starting score na 100, maintain lang nila dapat daw througout the semester.

[Archie C. Reyes @zymotweets]

Thank you @kylieminogue for spending 1,786 minutes with me this year on @Spotify. You are my #1. #SpotifyWrapped https://t.co/zXeLzSPx52

[Archie C. Reyes @zymotweets]

@marecto hahahahahhaha FANGIRL!